ISSN: 0973-7510

E-ISSN: 2581-690X

Research Article | Open Access
H.A. Arundathi1 , N. Prakash2, H.L. Halesh2 and K.C. Siddesh2
1Department of Microbiology, Karwar Institute of Medical Sciences, Karwar – 581 301, Karnataka, India.
2Department of Microbiology, Shimoga Institute of Medical Sciences (SIMS), Shimoga – 577 201, Karnataka, India.
J Pure Appl Microbiol. 2022;16(2):1004-1009 | Article Number: 7293 | © The Author(s). 2022
Received: 06/09/2021 | Accepted: 18/02/2022 | Published online: 17/05/2022
Issue online: June 2022

Enterococci infections, have drawn attention of clinicians due to rapid increase in high level aminoglycoside resistance (HLAR). This resistance predicts failure of β-lactam antibiotic and aminoglycoside combination, which is the current treatment of choice for serious enterococci infections. This led us to investigate about the prevalence of HLAR enterococci in our hospital setting in Shimoga, Karnataka. All the clinical samples received at Microbiology laboratory, McGan hospital, Shivamogga between June 2016 and December 2016 was considered for the study. Enterococci were identified and further speciated by following conventional method. Antibiotic susceptibility pattern of all the isolates was determined according to CLSI guidelines. High level gentamicin resistance was detected by disc diffusion method using 120µg gentamicin disc. A total of 64 Enterococci species were isolated from the clinical specimens. On speciation, Enterococcus faecalis (E. faecalis) accounted for 72% (46) of the total isolates, 24%(16) of the isolates were Enterococcus faecium (E. faecium)and 4% (2) isolates were Enterococcus durans (E. durans). High level gentamicin resistance was noted in 42% (27) among the total isolates. E. faecium was found to be more resistant compared to E. faecalis. E. durans was a sensitive strain. Our study reconfirms the high prevalence of HLAR in the clinical setting. The study stresses on the need for regular screening of HLAR in all Enterococci infections and revise the battery of drugs for its treatment according to the report.


Enterococcus, Enterococcus faecalis, Enterococcus faecium, high level aminoglycoside resistance, Gentamicin

Article Metrics

Article View: 60

Share This Article

© The Author(s) 2022. Open Access. This article is distributed under the terms of the Creative Commons Attribution 4.0 International License which permits unrestricted use, sharing, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.